Timolol Maleate



Indications and Reactions:

Role Indications Reactions
Primary
Glaucoma 47.4%
Intraocular Pressure Increased 20.1%
Drug Use For Unknown Indication 5.4%
Open Angle Glaucoma 4.9%
Product Used For Unknown Indication 4.4%
Ocular Hypertension 2.7%
Anterior Chamber Disorder 2.5%
Developmental Glaucoma 2.0%
Cardiac Failure Congestive 1.5%
Osteoporosis 1.5%
Dry Eye 1.2%
Hypertension 1.2%
Surgery 1.0%
Herpes Zoster 0.7%
Hypercholesterolaemia 0.7%
Intraocular Pressure Test Abnormal 0.7%
Accidental Exposure 0.5%
Age-related Macular Degeneration 0.5%
Angle Closure Glaucoma 0.5%
Arthritis 0.5%
Intraocular Pressure Increased 15.0%
Visual Impairment 11.7%
Visual Acuity Reduced 9.2%
Vision Blurred 8.3%
Ocular Hyperaemia 5.8%
Deafness 4.2%
Drug Ineffective 4.2%
Eye Haemorrhage 4.2%
Product Substitution Issue 4.2%
Skin Exfoliation 4.2%
Wheezing 4.2%
Corneal Deposits 3.3%
Pneumonia 3.3%
Sick Sinus Syndrome 3.3%
Bradycardia 2.5%
Conjunctivitis Allergic 2.5%
Deafness Unilateral 2.5%
Eye Irritation 2.5%
Glaucoma 2.5%
Lacrimation Increased 2.5%
Secondary
Glaucoma 33.3%
Open Angle Glaucoma 8.9%
Hypertension 8.6%
Intraocular Pressure Increased 7.6%
Cataract Operation 5.2%
Ocular Hypertension 4.5%
Drug Use For Unknown Indication 3.9%
Thyroid Disorder 3.9%
Product Used For Unknown Indication 3.7%
Postoperative Care 2.6%
Atrial Fibrillation 2.1%
Corneal Epithelium Defect 2.1%
Hypothyroidism 2.1%
Corneal Abscess 1.9%
Intraocular Lens Implant 1.8%
Keratitis Herpetic 1.8%
Ulcerative Keratitis 1.8%
Ill-defined Disorder 1.6%
Keratitis 1.5%
Endophthalmitis 1.1%
Corneal Deposits 17.2%
Visual Acuity Reduced 13.8%
Intraocular Pressure Increased 7.8%
Toxic Anterior Segment Syndrome 6.0%
Pneumonia 5.2%
Vision Blurred 5.2%
Visual Impairment 5.2%
Sick Sinus Syndrome 4.3%
Vitreous Haemorrhage 4.3%
Weight Decreased 4.3%
Hypersensitivity 3.4%
Cystoid Macular Oedema 2.6%
Drug Ineffective 2.6%
Eye Pain 2.6%
Hyperkalaemia 2.6%
Ocular Hyperaemia 2.6%
Paraesthesia 2.6%
Post Procedural Complication 2.6%
Prinzmetal Angina 2.6%
Skin Exfoliation 2.6%
Concomitant
Product Used For Unknown Indication 22.0%
Drug Use For Unknown Indication 16.7%
Glaucoma 15.1%
Hypertension 11.5%
Diabetes Mellitus 3.9%
Pain 3.9%
Prophylaxis 2.7%
Atrial Fibrillation 2.7%
Osteoporosis 2.7%
Rheumatoid Arthritis 2.4%
Depression 2.0%
Behcet's Syndrome 1.9%
Type 2 Diabetes Mellitus 1.8%
Gastrooesophageal Reflux Disease 1.8%
Multiple Myeloma 1.7%
Intraocular Pressure Increased 1.6%
Hyperlipidaemia 1.5%
Constipation 1.4%
Blood Cholesterol Increased 1.4%
Nausea 1.4%
Intraocular Pressure Increased 8.5%
Rash 8.3%
Weight Decreased 8.0%
Vision Blurred 7.4%
Visual Acuity Reduced 6.6%
Vomiting 6.6%
Death 6.0%
Wheezing 6.0%
Tremor 4.8%
Drug Ineffective 4.6%
Renal Failure Acute 4.3%
Pneumonia 4.0%
Mucosal Inflammation 3.4%
Urinary Tract Infection 3.4%
Weight Increased 3.4%
Blood Glucose Increased 3.1%
Ocular Hyperaemia 3.1%
Fatigue 2.8%
Myocardial Infarction 2.8%
Syncope 2.8%
Interacting
Glaucoma 50.0%
Essential Hypertension 20.0%
Erectile Dysfunction 10.0%
Keratopathy 10.0%
Postoperative Care 10.0%
Drug Interaction 33.3%
Memory Impairment 33.3%
Headache 16.7%
Visual Acuity Reduced 16.7%